Hunan Fangsheng Pharmaceutical Co., Ltd. (SHA:603998)

China flag China · Delayed Price · Currency is CNY
10.99
+0.01 (0.09%)
Apr 30, 2026, 3:00 PM CST
11.69%
Market Cap 4.83B
Revenue (ttm) 1.79B
Net Income (ttm) 306.52M
Shares Out 439.08M
EPS (ttm) 0.70
PE Ratio 15.70
Forward PE 13.24
Dividend 0.25 (2.28%)
Ex-Dividend Date Jan 16, 2026
Volume 8,438,600
Average Volume 9,015,236
Open 10.96
Previous Close 10.98
Day's Range 10.96 - 11.11
52-Week Range 9.48 - 13.50
Beta 0.45
RSI 52.57
Earnings Date Apr 25, 2026

About SHA:603998

Hunan Fangsheng Pharmaceutical Co., Ltd. engages in research, develops, produces, and sells traditional Chinese medicine industry and chemical pharmaceutical products in China. The company offers pharmaceutical manufacturing; and provides cardiovascular and cerebrovascular drugs, skeletal muscle system drugs, orthopedic drugs, respiratory drugs, pediatric drugs, gynecological drugs, and anti-infective drugs. The company's main products include Xuesetong dispersible tablets, Xuesetong tablets, Garcinia bone-strengthening tablets, Dieda Huoxue ca... [Read more]

Sector Healthcare
Founded 2002
Employees 1,807
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603998
Full Company Profile

Financial Performance

In 2025, SHA:603998's revenue was 1.75 billion, a decrease of -1.75% compared to the previous year's 1.78 billion. Earnings were 306.39 million, an increase of 20.05%.

Financial Statements

News

There is no news available yet.